CLOV

SEC source: 0000895345-23-000304 · form4.xml · nonDerivative · entry 1

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,455

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of May 15, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0000895345-23-000389 · form4.xml · nonDerivative · entry 1

Sharp Aric R · CIK 0001926602 · CEO of Value-Based Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,819

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 9, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on May 9, 2022, and timely reported on a Form 4 filed on May 10, 2022. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after May 9, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.

SEC source: 0000895345-23-000254 · form4.xml · nonDerivative · entry 1

Martin Joseph Richards · CIK 0001776869 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,817,684

F1 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on March 14, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 15, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after March 14, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 4

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,388,661

F4 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on March 14, 2023, of 25% of the original number of RSUs granted to the Reporting Person on March 14, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after March 14, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. The original grant of RSUs was timely reported on a Form 4 filed on Mach 16, 2022.

SEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 3

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,420,116

F3 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting of 1/3rd, of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The original grant was timely reported on a Form 4 filed on July 20, 2021.

SEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,421,397

F1 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021.

SEC source: 0000895345-23-000261 · form4.xml · derivative · entry 5

Garipalli Vivek · CIK 0001839260 · Director · Executive Chairperson · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,450,977

Underlying: Class A Common Stock · 1,569,594 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2023, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

SEC source: 0000895345-23-000261 · form4.xml · derivative · entry 4

Garipalli Vivek · CIK 0001839260 · Director · Executive Chairperson · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,020,571

Underlying: Class A Common Stock · 3,342,698 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2023, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

SEC source: 0000895345-23-000261 · form4.xml · derivative · entry 3

Garipalli Vivek · CIK 0001839260 · Director · Executive Chairperson · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,028,095

Underlying: Class B Common Stock · 3,342,698 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.underlying: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

SEC source: 0000895345-23-000261 · form4.xml · nonDerivative · entry 2

Garipalli Vivek · CIK 0001839260 · Director · Executive Chairperson · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2023, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

SEC source: 0000895345-23-000261 · form4.xml · nonDerivative · entry 1

Garipalli Vivek · CIK 0001839260 · Director · Executive Chairperson · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,569,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2023, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

SEC source: 0001628280-23-000468 · wf-form4_167295450617790.xml · nonDerivative · entry 1

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,462

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001628280-23-000462 · wf-form4_167295412723132.xml · nonDerivative · entry 1

Clinton Chelsea · CIK 0001530920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,654

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001628280-23-000470 · wf-form4_167295461765065.xml · nonDerivative · entry 1

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,462

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001628280-23-000489 · wf-form4_167295597065913.xml · nonDerivative · entry 1

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,656

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001628280-23-000467 · wf-form4_167295440741586.xml · nonDerivative · entry 1

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,870

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001628280-23-000464 · wf-form4_167295423886671.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,067

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001628280-23-000460 · wf-form4_167295383214450.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,454,877

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of January 3, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 3, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001628280-23-000265 · wf-form4_167286964219043.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,429,585

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of January 1, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 1, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001952723-22-000006 · wf-form4_166984432158034.xml · nonDerivative · entry 1

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,665

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of November 28, 2022, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001628280-22-025505 · wf-form4_166422960816234.xml · derivative · entry 3

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 27,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

F3 · shares: The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

F3 · derivative.exercise_date: The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

F3 · derivative.expiration_date: The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

SEC source: 0001628280-22-025505 · wf-form4_166422960816234.xml · nonDerivative · entry 2

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,471

F2 · shares: Represents shares of Class A common stock underlying a time-based RSU. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.

SEC source: 0001628280-22-025505 · wf-form4_166422960816234.xml · nonDerivative · entry 1

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

SEC source: 0001628280-22-025510 · wf-form4_166422979146388.xml · derivative · entry 3

Clinton Chelsea · CIK 0001530920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 38,392 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

F3 · derivative.expiration_date: One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

SEC source: 0001628280-22-025510 · wf-form4_166422979146388.xml · nonDerivative · entry 2

Clinton Chelsea · CIK 0001530920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,663

F2 · shares: Represents shares of Class A common stock underlying a time-based RSUs. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.

SEC source: 0001628280-22-025510 · wf-form4_166422979146388.xml · nonDerivative · entry 1

Clinton Chelsea · CIK 0001530920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,392

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

SEC source: 0001628280-22-025509 · wf-form4_166422975290506.xml · derivative · entry 3

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 27,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

F3 · derivative.expiration_date: The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

SEC source: 0001628280-22-025509 · wf-form4_166422975290506.xml · nonDerivative · entry 2

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,471

F2 · shares: Represents shares of Class A common stock underlying a time-based RSUs. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.

SEC source: 0001628280-22-025509 · wf-form4_166422975290506.xml · nonDerivative · entry 1

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

SEC source: 0001628280-22-025508 · wf-form4_166422970848030.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,076

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSU"). One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.

SEC source: 0001628280-22-025506 · wf-form4_166422966400809.xml · derivative · entry 3

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 25,608 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

F3 · derivative.expiration_date: One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

SEC source: 0001628280-22-025506 · wf-form4_166422966400809.xml · nonDerivative · entry 2

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,879

F2 · shares: Represents shares of Class A common stock underlying a time-based RSU. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.

SEC source: 0001628280-22-025506 · wf-form4_166422966400809.xml · nonDerivative · entry 1

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,608

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

SEC source: 0001628280-22-025242 · wf-form4_166370616282676.xml · nonDerivative · entry 1

Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 872,821

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001628280-22-025244 · wf-form4_166370634567239.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,100,895

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001628280-22-022231 · wf-form4_166016358247135.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,695,072

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of August 8, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 8, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001832406-22-000005 · wf-form4_165886902127599.xml · nonDerivative · entry 1

Leffler Scott J. · CIK 0001832406 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,052,016

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of July 25, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of July 25, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001937412-22-000008 · wf-form4_165886719563485.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,805

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on September 22, 2022, the date of the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service as a member of the Board through such vesting date.

SEC source: 0001938197-22-000007 · wf-form4_165826425731010.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,694,915

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of July 18, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of July 18, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001926602-22-000004 · wf-form4_165221947391488.xml · nonDerivative · entry 1

Sharp Aric R · CIK 0001926602 · CEO of Value Based Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,967

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of May 9, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of May 9, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001628280-22-006267 · wf-form4_164737711293235.xml · nonDerivative · entry 1

Martin Joseph Richards · CIK 0001776869 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,100,775

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of March 14, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of March 14, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001628280-22-006433 · wf-form4_164746913247003.xml · nonDerivative · entry 1

Singh Prabhdeep · CIK 0001870027 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 519,465

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of March 14, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of March 14, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001628280-22-006439 · wf-form4_164746936511138.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 747,539

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of March 14, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of March 14, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001628280-22-006156 · wf-form4_164734580175403.xml · nonDerivative · entry 1

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,100

F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $3.085 to $3.14 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001628280-22-005169 · wf-form4_164643267344851.xml · nonDerivative · entry 1

Clinton Chelsea · CIK 0001530920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.525 to $2.530 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001628280-22-001707 · wf-form4_164384610584079.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,591

F1 · shares: Represents shares of Class A common stock underlying time-based restricted stock units ("RSUs") that vest in three equal annual installments on January 31, 2022, January 1, 2023 and January 1, 2024. On July 16, 2021, the Reporting Person was granted a performance-based restricted stock unit award, and on January 31, 2022, the Talent and Compensation Committee of the Board of Directors certified the achievement of certain of the performance criteria, resulting in the grant of the RSUs.

SEC source: 0000895345-23-000255 · form4.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,310

F1 · security: This Form 4/A, amends the original Form 4, filed on February 2, 2022, solely to report the number of shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on January 31, 2022, of 1/3rd of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The RSUs vest in equal installments on January 31, 2022, January 1, 2023 and January 1, 2024.

F2 · shares: The original Form 4 inadvertently omitted the 1,281 shares that were withheld in connection with the January 31, 2022 vesting event.

SEC source: 0001628280-22-000724 · wf-form4_164195413048020.xml · derivative · entry 2

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,100

Underlying: Class A Common Stock · 27,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date.

F2 · derivative.expiration_date: The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date.

SEC source: 0001628280-22-000724 · wf-form4_164195413048020.xml · nonDerivative · entry 1

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-22-000725 · wf-form4_164195418269205.xml · derivative · entry 2

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,100

Underlying: Class A Common Stock · 27,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date.

F2 · derivative.expiration_date: The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date.